Local Institution

Durham, North Carolina 27710

0 studies enrolling now · 13 studies all time

What they study most

Arthritis, Rheumatoid, Bipolar Disorder, Bladder Cancer, Bladder Neoplasms, Breast Cancer, Cancer, Congestive Heart Failure, Diabetes Mellitus, Essential Thrombocythemia, Gastrointestinal Neoplasms, Kawasaki Disease, Kidney Neoplasms

Studies at this site

• An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer — Completed
• Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003) — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients — Completed
• Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode — Completed
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode — Withdrawn before enrolling
• PPAR - Combination With Metformin — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies — Stopped early
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early